Composition for relieving insulin resistance and preparation method thereof
By extracting panax notoginseng polysaccharide and total saponin react with vitamin D and urfacic acid, and combining with trunk acetamin, retinol, veratol, and probiotic microspheres, a composition that relieves insulin resistance is formed to relieve insulin resistance. , solves the shortcomings of insulin resistance treatment in gestational diabetes, significantly improves insulin sensitivity and blood sugar levels, and reduces inflammatory response and oxidative stress.
Patent Information
- Application Number
- CN202411117134.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-22
AI Technical Summary
Treatment of insulin resistance in gestational diabetes is insufficient prior art, especially few probiotic products for improving insulin sensitivity and reducing inflammatory responses, leading to serious health risks of gestational diabetes.
Complexes are prepared by extracting panax notoginseng polysaccharide and total saponin reacting with vitamin D and urfacic acid, and co-crystallize with tillerine, retinol and verrugol, combined with probiotic microspheres to form a relief insulin Resistant compositions, improve bioavailability and efficacy.
This composition significantly improves insulin sensitivity, regulates blood sugar levels by protecting the intestinal barrier, reducing inflammatory responses and oxidative stress, effectively alleviates gestational diabetes, improves bioavailability and reduces the risk of allergic reactions.
Abstract
Description
Technical Field
[0001] The present invention relates to the field of medical technology, and in particular to a composition for alleviating insulin resistance and a preparation method thereof. Background Art
[0002] Gestational diabetes is a pregnancy complication characterized by high blood sugar. Although the cause is unknown, current studies believe that the occurrence of gestational diabetes is related to insulin resistance and impaired pancreatic beta cell function. The incidence of gestational diabetes ranges from 0.6% to 15% due to different regions, races and diagnostic criteria. High-risk factors for its onset include high pre-pregnancy body mass index, sedentary lifestyle, older age at conception or genetics. Gestational diabetes seriously threatens the health of mother and child. Pregnant women with gestational diabetes have a significantly increased risk of developing type 2 diabetes after delivery. Moreover, the risk of cardiovascular disease in pregnant women with gestational diabetes is much higher than that of non-gestational diabetes. Pregnant women with gestational diabetes have an increased rate of fetal macrosomia and intrauterine growth retardation, an increased rate of neonatal respiratory distress syndrome, and an increased risk of type 2 diabetes in the future. Therefore, some studies believe that gestational diabetes is an early form of type 2 diabetes. In other words, gestational diabetes is a pregnancy manifestation of type 2 diabetes.
[0003] For a long time, the pathogenesis of gestational diabetes has been a topic of academic discussion. The currently accepted theory is that the occurrence of gestational diabetes is related to insulin resistance and β-cell functional damage. Insulin resistance refers to a state in which the target organs of insulin have a decreased sensitivity to the effects of insulin, that is, a state in which a normal dose of insulin produces a biological effect lower than normal. In layman's terms, insulin is still the same insulin as before, but the target organs no longer listen to its instructions. As the only glucose-lowering hormone in the body, it has become ineffective and cannot lower blood sugar.
[0004] In general, insulin resistance is considered to be a decreased sensitivity or responsiveness to the metabolic effects of insulin, including insulin-mediated glucose disposal. Insulin resistance syndrome is defined as a disease characterized by severely weakened insulin action due to functional impairment of the insulin receptor or its downstream signaling molecules. The syndrome is divided into two types: hereditary insulin resistance syndrome caused by genetic abnormalities and beta-type insulin resistance syndrome caused by insulin receptor autoantibodies. The most common type of insulin resistance is associated with a condition called metabolic syndrome. Insulin resistance syndrome can develop into full-blown type 2 diabetes. Postprandial hyperglycemia is common, in which the pancreatic beta cells are unable to produce enough insulin to maintain normal blood sugar levels. The inability of the beta cells to secrete more insulin under conditions of hyperglycemia is a characteristic of the transition from insulin resistance syndrome to type 2 diabetes.
[0005] Intestinal flora is closely related to blood sugar metabolism. For example, a bacterium in the intestine called Akkermansia Muciniphila plays an important role in blood sugar control. It can synthesize a membrane protein that can interact with IFN-gamma through the human body's Irgm-1 receptor, causing the latter's expression to decrease, thereby reducing the negative impact of the immune system on sugar metabolism and improving diabetes. At present, there are few probiotic products for alleviating insulin resistance. Therefore, it is very meaningful to provide a probiotic product to improve symptoms caused by insulin resistance. Summary of the invention
[0006] The purpose of the present invention is to provide a composition for alleviating insulin resistance and a preparation method thereof, which can improve insulin resistance in pregnant women and effectively regulate gestational diabetes by protecting the intestinal barrier, reducing inflammatory response, reducing oxidative stress, improving insulin sensitivity, and regulating blood sugar levels, and has broad application prospects.
[0007] The technical solution of the present invention is achieved in this way:
[0008] The invention provides a method for preparing a composition for alleviating insulin resistance. The method comprises the following steps: extracting Panax notoginseng to obtain Panax notoginseng polysaccharide and Panax notoginseng total saponins, reacting Panax notoginseng polysaccharide with vitamin D to obtain a Panax notoginseng polysaccharide / VD complex, reacting Panax notoginseng total saponins with ursolic acid to obtain a Panax notoginseng total saponins / ursolic acid complex, and uniformly mixing the complex with berberine / retinol / resveratrol cocrystal and probiotic microspheres to obtain the composition for alleviating insulin resistance.
[0009] As a further improvement of the present invention, the following steps are included:
[0010] S1. Extraction of notoginseng polysaccharide and total saponin: adding notoginseng powder to water, heating to boiling for extraction, filtering, retaining the solid residue, adding ethanol to the filtrate for precipitation, filtering, washing, and drying to obtain notoginseng polysaccharide; mixing the filtrate with the solid residue, heating for extraction, filtering, decompressing the filtrate to recover ethanol, adding acetone to the liquid for precipitation, filtering, washing, and drying to obtain notoginseng total saponin;
[0011] S2. Preparation of Panax notoginseng total saponins / ursolic acid complex: adding Panax notoginseng total saponins to ethanol aqueous solution, adding catalyst and ursolic acid, heating to boiling for reaction, separating the catalyst, adding ether for precipitation, filtering, washing, and drying to obtain Panax notoginseng total saponins / ursolic acid complex;
[0012] S3. Preparation of Panax notoginseng polysaccharide / VD complex: adding Panax notoginseng polysaccharide to ethanol aqueous solution, adding catalyst and vitamin D, heating to boiling reaction, separating the catalyst, adding acetone for precipitation, filtering, washing, and drying to obtain Panax notoginseng polysaccharide / VD complex;
[0013] S4. Preparation of cocrystals: dissolving berberine in water to obtain solution A; dissolving retinol in ethanol to obtain solution B; dissolving resveratrol in acetone to obtain solution C; mixing solution A, solution B, and solution C evenly, evaporating them in an open air to form crystals, filtering, washing, and drying to obtain berberine / retinol / resveratrol cocrystals;
[0014] S5. Preparation of probiotic microspheres: Lactobacillus plantarum, Bifidobacterium lactis, and Bifidobacterium animalis were added to water, sodium alginate, lecithin, and arabinose were added, stirred and mixed, and then added dropwise to fish oil, emulsified, and calcium chloride solution was added dropwise, solidified at room temperature, filtered, washed, and freeze-dried to obtain probiotic microspheres;
[0015] S6. Preparation of a composition for alleviating insulin resistance: evenly mix notoginseng total saponin / ursolic acid complex, notoginseng polysaccharide / VD complex, berberine / retinol / resveratrol cocrystal, and probiotic microspheres to prepare a composition for alleviating insulin resistance.
[0016] As a further improvement of the present invention, the solid-to-liquid ratio of Panax notoginseng powder and water in step S1 is 1:5-7 g / mL, the time for heating to boiling extraction is 2-4 hours, ethanol is added until the ethanol content of the system is 75-85wt%, the time for heating extraction is 1-2 hours, and acetone is added until the acetone content of the system is 70-80wt%.
[0017] As a further improvement of the present invention, the ethanol content in the ethanol aqueous solution in step S2 is 40-60wt%, the mass ratio of the Panax notoginseng total saponins, the catalyst and ursolic acid is 10:0.1-0.2:4-5, and the time for heating to boiling reaction is 4-6h.
[0018] As a further improvement of the present invention, the mass ratio of Panax notoginseng polysaccharide, catalyst and vitamin D in step S3 is 12-15:0.1-0.2:3-5, and the time for heating to boiling reaction is 3-5h.
[0019] Preferably, the catalyst is p-toluenesulfonic acid or p-toluenesulfonic acid immobilized microspheres, and the preparation method is as follows: add 10g of silicon oxide microspheres to 200mL of Tris-HCl solution with pH=8.5, add 3g of tannic acid, heat to 40°C, stir and react for 2h, filter, add the solid to 50mL of ethanol, add 5g of p-toluenesulfonic acid, volatilize the solvent, wash, dry, and obtain the catalyst. After the surface of the catalyst is modified with tannic acid, the loading amount of p-toluenesulfonic acid is increased by hydrogen bonding, thereby greatly improving the catalytic efficiency, and the catalyst is also easy to separate and reuse multiple times, reducing the reaction cost.
[0020] As a further improvement of the present invention, in step S4, the mass ratio of berberine, retinol and resveratrol is 1-2:0.5-1:1.2-1.5, and the open volatilization time is 3-5 days.
[0021] As a further improvement of the present invention, the mass ratio of Lactobacillus plantarum, Bifidobacterium lactis, Bifidobacterium animalis, sodium alginate, lecithin and arabinose in step S5 is 3-5:1-2:2-3:4-6:0.2-0.4:1-2.
[0022] As a further improvement of the present invention, the mass ratio of the Panax notoginseng total saponins / ursolic acid complex, Panax notoginseng polysaccharide / VD complex, berberine / retinol / resveratrol cocrystal, and probiotic microspheres in step S6 is 4-6:3-5:1-2:10.
[0023] As a further improvement of the present invention, the present invention specifically comprises the following steps:
[0024] S1. Extraction of notoginseng polysaccharide and total saponin: add notoginseng powder to water, wherein the solid-liquid ratio of notoginseng powder to water is 1:5-7g / mL, heat to boiling and extract for 2-4h, filter, retain the solid residue, add ethanol to the filtrate until the ethanol content of the system is 75-85wt%, precipitate, filter, wash, and dry to obtain notoginseng polysaccharide; mix the filtrate with the solid residue, heat and extract for 1-2h, filter, reduce the pressure of the filtrate to recover ethanol, add acetone to the liquid until the acetone content of the system is 70-80wt%, precipitate, filter, wash, and dry to obtain notoginseng total saponin;
[0025] S2. Preparation of Panax notoginseng total saponins / ursolic acid complex: add 10 parts by weight of Panax notoginseng total saponins to an ethanol aqueous solution, add 0.1-0.2 parts by weight of a catalyst and 4-5 parts by weight of ursolic acid, heat to boiling and react for 4-6 hours, separate the catalyst, add ether to precipitate, filter, wash, and dry to obtain a Panax notoginseng total saponins / ursolic acid complex;
[0026] The ethanol content in the ethanol aqueous solution is 40-60wt%;
[0027] S3. Preparation of Panax notoginseng polysaccharide / VD complex: adding 12-15 parts by weight of Panax notoginseng polysaccharide to an ethanol aqueous solution, adding 0.1-0.2 parts by weight of a catalyst and 3-5 parts by weight of vitamin D, heating to boiling for 3-5 hours, separating the catalyst, adding acetone for precipitation, filtering, washing, and drying to obtain a Panax notoginseng polysaccharide / VD complex;
[0028] The ethanol content in the ethanol aqueous solution is 40-60wt%;
[0029] S4. Preparation of cocrystals: 1-2 parts by weight of berberine was dissolved in water to obtain solution A; 0.5-1 parts by weight of retinol was dissolved in ethanol to obtain solution B; 1.2-1.5 parts by weight of resveratrol was dissolved in acetone to obtain solution C; solution A, solution B, and solution C were mixed uniformly, and evaporated open for 3-5 days to form crystals, which were filtered, washed, and dried to obtain berberine / retinol / resveratrol cocrystals;
[0030] S5. Preparation of probiotic microspheres: 3-5 parts by weight of Lactobacillus plantarum, 1-2 parts by weight of Bifidobacterium lactis, 2-3 parts by weight of Bifidobacterium animalis were added to water, 4-6 parts by weight of sodium alginate, 0.2-0.4 parts by weight of lecithin and 1-2 parts by weight of arabinose were added, stirred and mixed, and then added dropwise to fish oil, emulsified, and calcium chloride solution was added dropwise, solidified at room temperature, filtered, washed, and freeze-dried to obtain probiotic microspheres;
[0031] S6. Preparation of a composition for alleviating insulin resistance: mix 4-6 parts by weight of Panax notoginseng total saponins / ursolic acid complex, 3-5 parts by weight of Panax notoginseng polysaccharide / VD complex, 1-2 parts by weight of berberine / retinol / resveratrol cocrystal, and 10 parts by weight of probiotic microspheres to obtain a composition for alleviating insulin resistance.
[0032] The present invention further protects a composition for alleviating insulin resistance prepared by the above preparation method.
[0033] The present invention has the following beneficial effects:
[0034] Vitamin D3 is a fat-soluble steroid derivative generated by food intake or vitamin D3 precursors exposed to ultraviolet light. Different vitamin D3 precursors are converted into 1,25(OH)2D3 under the catalytic action of enzymes. 1,25(OH)2D3 can bind to vitamin D3 on the surface of insulin receptors to activate insulin receptor genes and enhance insulin receptor sensitivity to insulin. It can also inhibit insulin resistance by regulating lipid metabolism and inhibiting the expression of inflammatory factors. However, vitamin D3 is also not easily soluble in water, resulting in reduced bioavailability.
[0035] Ursolic acid is a triterpenoid compound found in natural plants. The combination of ursolic acid and rosiglitazone can activate the IRS-PI3-Akt pathway, induce glucose transporter 4 translocation and increase insulin receptor expression, and improve insulin sensitivity. Ursolic acid can reduce the body weight of rats with insulin resistance induced by a high-fat diet, reduce fasting insulin levels, and improve insulin sensitivity. It is speculated that ursolic acid promotes insulin expression by inhibiting the expression of protein tyrosine phosphatase 1B in rats, thereby improving rat insulin sensitivity. However, the poor water solubility of ursolic acid leads to its low bioavailability.
[0036] Panax notoginseng contains abundant polysaccharides and total saponins, which have abundant hydroxyl and carboxyl structures in their structure. Under the action of catalyst, they can react with vitamin D or ursolic acid to obtain Panax notoginseng total saponins / ursolic acid complex and Panax notoginseng polysaccharide / VD complex, which greatly improves the water solubility and bioavailability of the product. After degradation, intermediate products such as Panax notoginseng saponins, Panax notoginseng polysaccharides, vitamin D and ursolic acid can be obtained. Among them, Panax notoginseng saponins are not only TGR5 agonists, but also FXR antagonists, which can effectively inhibit insulin resistance. Panax notoginseng polysaccharides are composed of heteropolysaccharides (D-glucose, D-galactose and L-arabinose) and glucans, which have the effects of enhancing immunity, regulating inflammatory response, improving oxidative stress, etc., so as to improve the function of organs and thus improve insulin resistance.
[0037] Berberine plays a hypoglycemic role by improving insulin resistance through the dependent protein kinase signaling pathway, insulin signaling pathway, nuclear factor-κB signaling pathway and other signaling pathways, and berberine has good water solubility and good bioavailability, but there are problems such as easy to cause allergic reactions. Retinol is a safe food that can inhibit the expression of retinol binding protein 4, inhibit its paracrine function, reduce the production of inflammatory factors and improve insulin resistance, but retinol is poorly soluble in water and has the problem of poor bioavailability. Resveratrol is a good antioxidant that can greatly reduce the damage of autoimmunity to pancreatic B cells, increase the number of pancreatic islet cells and enhance pancreatic cell function, but it is also difficult to dissolve in water and has poor bioavailability, and sometimes it is easy to cause allergic reactions. The inventor found that after berberine, resveratrol and retinol were mixed to form a co-crystal, not only the water solubility of the co-crystal was greatly improved, the bioavailability of the product was improved, but also the irritation of the co-crystal to the human body was significantly reduced, and the allergic reaction was reduced.
[0038] Probiotics also have a significant effect on improving insulin resistance. On the one hand, they can protect the intestinal barrier, improve insulin sensitivity and reduce oxidative stress by producing a large amount of short-chain fatty acids. On the other hand, probiotics can promote the secretion of incretin hormone GLP-1, which helps to relieve hyperglycemia, significantly reduce fasting blood sugar levels, improve insulin resistance, and regulate serum blood lipids and blood sugar indicators. Intestinal microorganisms also have a special sugar metabolism mechanism that can help break down undigested carbohydrates, affect the host's energy absorption, thereby regulating blood sugar levels and improving insulin resistance. The storage period of the survival rate of probiotics is greatly improved after embedding, and the addition of arabinose can promote the growth of probiotics.
[0039] The composition for alleviating insulin resistance prepared by the present invention improves insulin resistance in pregnant women and effectively regulates gestational diabetes by protecting the intestinal barrier, reducing inflammatory response, reducing oxidative stress, improving insulin sensitivity, and regulating blood sugar levels, and has broad application prospects. DETAILED DESCRIPTION
[0040] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0041] Lactobacillus plantarum, Bifidobacterium lactis, and Bifidobacterium animalis, 10 billion cfu / g, were purchased from Shandong Zhongke Jiayi Bioengineering Technology Co., Ltd.
[0042] Preparation Example 1 Preparation of p-Toluenesulfonic Acid Immobilized Microspheres
[0043] Here’s how:
[0044] 10 g of silica microspheres were added to 200 mL of Tris-HCl solution with a pH of 8.5, 3 g of tannic acid was added, the solution was heated to 40°C, stirred for reaction for 2 h, filtered, the solid was added to 50 mL of ethanol, 5 g of p-toluenesulfonic acid was added, the solvent was evaporated, washed, and dried to obtain p-toluenesulfonic acid-immobilized microspheres.
[0045] Example 1
[0046] This embodiment provides a method for preparing a composition for alleviating insulin resistance, which specifically comprises the following steps:
[0047] S1. Extraction of notoginseng polysaccharide and total saponin: add 100g of notoginseng powder to 500mL of water, heat to boiling and extract for 2h, filter, retain the solid residue, add ethanol to the filtrate until the ethanol content of the system is 75wt%, precipitate for 1h, filter, wash, and dry to obtain notoginseng polysaccharide; mix the filtrate with the solid residue, heat and extract for 1h, filter, reduce the pressure of the filtrate to recover ethanol, add acetone to the liquid until the acetone content of the system is 70wt%, precipitate for 1h, filter, wash, and dry to obtain notoginseng total saponin;
[0048] S2. Preparation of Panax notoginseng total saponins / ursolic acid complex: 10 g Panax notoginseng total saponins were added to 200 mL 40 wt% ethanol aqueous solution, 0.1 g p-toluenesulfonic acid and 4 g ursolic acid were added, and the mixture was heated to boiling for 4 h, the catalyst was separated, ether was added for precipitation, filtered, washed, and dried to obtain Panax notoginseng total saponins / ursolic acid complex;
[0049] S3. Preparation of Panax notoginseng polysaccharide / VD complex: 12 g Panax notoginseng polysaccharide was added to 200 mL 40 wt% ethanol aqueous solution, 0.1 g p-toluenesulfonic acid and 3 g vitamin D were added, and the mixture was heated to boiling for 3 h, the catalyst was separated, acetone was added for precipitation, the mixture was filtered, washed and dried to obtain Panax notoginseng polysaccharide / VD complex;
[0050] S4. Preparation of cocrystals: 1 g of berberine was dissolved in 200 mL of water to obtain solution A; 0.5 g of retinol was dissolved in 100 mL of ethanol to obtain solution B; 1.2 g of resveratrol was dissolved in 100 mL of acetone to obtain solution C; solution A, solution B, and solution C were mixed evenly, and evaporated for 3 days to form crystals, which were filtered, washed, and dried to obtain berberine / retinol / resveratrol cocrystals;
[0051] S5. Preparation of probiotic microspheres: 3 g of Lactobacillus plantarum, 1 g of Bifidobacterium lactis, and 2 g of Bifidobacterium animalis were added to 300 mL of water, 4 g of sodium alginate, 0.2 g of lecithin and 1 g of arabinose were added, and the mixture was stirred for 20 min, and then added dropwise to 500 mL of fish oil, emulsified at 7000 r / min for 15 min, and 10 mL of 5 wt% calcium chloride solution was added dropwise, and the mixture was cured at room temperature for 30 min, filtered, washed, and freeze-dried to obtain probiotic microspheres;
[0052] S6. Preparation of a composition for alleviating insulin resistance: 4 g of Panax notoginseng total saponins / ursolic acid complex, 3 g of Panax notoginseng polysaccharide / VD complex, 1 g of berberine / retinol / resveratrol cocrystal, and 10 g of probiotic microspheres were stirred and mixed for 10 minutes to prepare a composition for alleviating insulin resistance.
[0053] Example 2
[0054] This embodiment provides a method for preparing a composition for alleviating insulin resistance, which specifically comprises the following steps:
[0055] S1. Extraction of notoginseng polysaccharide and total saponin: add 100g of notoginseng powder to 700mL of water, heat to boiling and extract for 4h, filter, retain the solid residue, add ethanol to the filtrate until the ethanol content of the system is 85wt%, precipitate for 1h, filter, wash, and dry to obtain notoginseng polysaccharide; mix the filtrate with the solid residue, heat and extract for 2h, filter, reduce the pressure of the filtrate to recover ethanol, add acetone to the liquid until the acetone content of the system is 80wt%, precipitate for 1h, filter, wash, and dry to obtain notoginseng total saponin;
[0056] S2. Preparation of Panax notoginseng total saponins / ursolic acid complex: 10 g Panax notoginseng total saponins were added to 200 mL 60 wt% ethanol aqueous solution, 0.2 g p-toluenesulfonic acid immobilized microspheres prepared in Preparation Example 1 and 5 g ursolic acid were added, and the mixture was heated to boiling for 6 h. The p-toluenesulfonic acid immobilized microspheres prepared in Preparation Example 1 were separated, ether was added for precipitation, filtered, washed, and dried to obtain a Panax notoginseng total saponins / ursolic acid complex;
[0057] S3. Preparation of Panax notoginseng polysaccharide / VD complex: 15 g Panax notoginseng polysaccharide was added to 200 mL 60 wt% ethanol aqueous solution, 0.2 g p-toluenesulfonic acid immobilized microspheres prepared in Preparation Example 1 and 5 g vitamin D were added, and the mixture was heated to boiling for 5 h. The p-toluenesulfonic acid immobilized microspheres prepared in Preparation Example 1 were separated, acetone was added for precipitation, filtered, washed, and dried to obtain a Panax notoginseng polysaccharide / VD complex;
[0058] S4. Preparation of cocrystals: 2 g of berberine was dissolved in 200 mL of water to obtain solution A; 1 g of retinol was dissolved in 100 mL of ethanol to obtain solution B; 1.5 g of resveratrol was dissolved in 100 mL of acetone to obtain solution C; solution A, solution B, and solution C were mixed evenly, and evaporated open for 5 days to form crystals, which were filtered, washed, and dried to obtain berberine / retinol / resveratrol cocrystals;
[0059] S5. Preparation of probiotic microspheres: 5 g of Lactobacillus plantarum, 2 g of Bifidobacterium lactis, and 3 g of Bifidobacterium animalis were added to 300 mL of water, 6 g of sodium alginate, 0.4 g of lecithin and 2 g of arabinose were added, stirred and mixed for 20 min, added dropwise to 500 mL of fish oil, emulsified at 7000 r / min for 15 min, 10 mL of 5 wt% calcium chloride solution was added dropwise, cured at room temperature for 30 min, filtered, washed, and freeze-dried to obtain probiotic microspheres;
[0060] S6. Preparation of a composition for alleviating insulin resistance: 6 g of Panax notoginseng total saponins / ursolic acid complex, 5 g of Panax notoginseng polysaccharide / VD complex, 2 g of berberine / retinol / resveratrol cocrystal, and 10 g of probiotic microspheres were stirred and mixed for 10 minutes to prepare a composition for alleviating insulin resistance.
[0061] Example 3
[0062] This embodiment provides a method for preparing a composition for alleviating insulin resistance, which specifically comprises the following steps:
[0063] S1. Extraction of notoginseng polysaccharide and total saponin: add 100g of notoginseng powder to 600mL of water, heat to boiling and extract for 3h, filter, retain the solid residue, add ethanol to the filtrate until the ethanol content of the system is 80wt%, precipitate for 1h, filter, wash, and dry to obtain notoginseng polysaccharide; mix the filtrate with the solid residue, heat and extract for 1.5h, filter, reduce the pressure of the filtrate to recover ethanol, add acetone to the liquid until the acetone content of the system is 75wt%, precipitate for 1h, filter, wash, and dry to obtain notoginseng total saponin;
[0064] S2. Preparation of Panax notoginseng total saponins / ursolic acid complex: 10 g of Panax notoginseng total saponins were added to 200 mL of 50 wt% ethanol aqueous solution, 0.15 g of p-toluenesulfonic acid immobilized microspheres prepared in Preparation Example 1 and 4.5 g of ursolic acid were added, and the mixture was heated to boiling for 5 h. The p-toluenesulfonic acid immobilized microspheres prepared in Preparation Example 1 were separated, ether was added for precipitation, filtered, washed, and dried to obtain a Panax notoginseng total saponins / ursolic acid complex;
[0065] S3. Preparation of Panax notoginseng polysaccharide / VD complex: 13.6 g Panax notoginseng polysaccharide was added to 200 mL 50 wt% ethanol aqueous solution, 0.15 g p-toluenesulfonic acid immobilized microspheres prepared in Preparation Example 1 and 4 g vitamin D were added, and the mixture was heated to boiling for 4 h. The p-toluenesulfonic acid immobilized microspheres prepared in Preparation Example 1 were separated, acetone was added for precipitation, filtered, washed, and dried to obtain a Panax notoginseng polysaccharide / VD complex;
[0066] S4. Preparation of cocrystals: 1.6 g of berberine was dissolved in 200 mL of water to obtain solution A; 0.7 g of retinol was dissolved in 100 mL of ethanol to obtain solution B; 1.3 g of resveratrol was dissolved in 100 mL of acetone to obtain solution C; solution A, solution B, and solution C were mixed evenly, and evaporated open for 4 days to form crystals, which were filtered, washed, and dried to obtain berberine / retinol / resveratrol cocrystals;
[0067] S5. Preparation of probiotic microspheres: 4 g of Lactobacillus plantarum, 1.4 g of Bifidobacterium lactis, and 2.7 g of Bifidobacterium animalis were added to 300 mL of water, 5 g of sodium alginate, 0.3 g of lecithin, and 1.6 g of arabinose were added, stirred and mixed for 20 min, added dropwise to 500 mL of fish oil, emulsified at 7000 r / min for 15 min, 10 mL of 5 wt% calcium chloride solution was added dropwise, cured at room temperature for 30 min, filtered, washed, and freeze-dried to obtain probiotic microspheres;
[0068] S6. Preparation of a composition for alleviating insulin resistance: 5 g of Panax notoginseng total saponins / ursolic acid complex, 4 g of Panax notoginseng polysaccharide / VD complex, 1.7 g of berberine / retinol / resveratrol cocrystal, and 10 g of probiotic microspheres were stirred and mixed for 10 minutes to prepare a composition for alleviating insulin resistance.
[0069] Comparative Example 1
[0070] Compared with Example 3, the difference is that berberine is not added in step S4.
[0071] The details are as follows:
[0072] S4. Preparation of cocrystals: Dissolve 0.7 g of retinol in 100 mL of ethanol to obtain solution B; dissolve 1.3 g of resveratrol in 100 mL of acetone to obtain solution C; mix solution B and solution C evenly, evaporate them in an open air for 4 days to form crystals, filter, wash, and dry to obtain retinol / resveratrol cocrystals.
[0073] Comparative Example 2
[0074] Compared with Example 3, the difference is that no retinol is added in step S4.
[0075] The details are as follows:
[0076] S4. Preparation of cocrystals: Dissolve 1.6 g of berberine in 200 mL of water to obtain solution A; dissolve 1.3 g of resveratrol in 100 mL of acetone to obtain solution C; mix solution A and solution C evenly, evaporate them in an open air for 4 days to form crystals, filter, wash, and dry to obtain berberine / resveratrol cocrystals.
[0077] Comparative Example 3
[0078] Compared with Example 3, the difference is that resveratrol is not added in step S4.
[0079] The details are as follows:
[0080] S4. Preparation of cocrystals: Dissolve 1.6 g of berberine in 200 mL of water to obtain solution A; dissolve 0.7 g of retinol in 100 mL of ethanol to obtain solution B; mix solution A and solution B evenly, evaporate them open for 4 days to form crystals, filter, wash, and dry to obtain berberine / retinol cocrystals.
[0081] Comparative Example 4
[0082] Compared with Example 3, the difference is that no notoginseng total saponins / ursolic acid complex is added in step S6.
[0083] The details are as follows:
[0084] S6. Preparation of a composition for alleviating insulin resistance: 9 g of Panax notoginseng polysaccharide / VD complex, 1.7 g of berberine / retinol / resveratrol cocrystal, and 10 g of probiotic microspheres were stirred and mixed for 10 minutes to prepare a composition for alleviating insulin resistance.
[0085] Comparative Example 5
[0086] Compared with Example 3, the difference is that no notoginseng polysaccharide / VD complex is added in step S6.
[0087] The details are as follows:
[0088] S6. Preparation of a composition for alleviating insulin resistance: 9 g of Panax notoginseng total saponins / ursolic acid complex, 1.7 g of berberine / retinol / resveratrol cocrystal, and 10 g of probiotic microspheres were stirred and mixed for 10 minutes to prepare a composition for alleviating insulin resistance.
[0089] Comparative Example 6
[0090] Compared with Example 3, the difference is that berberine / retinol / resveratrol co-crystal is not added in step S6.
[0091] The details are as follows:
[0092] S6. Preparation of a composition for alleviating insulin resistance: 5 g of notoginseng total saponin / ursolic acid complex, 4 g of notoginseng polysaccharide / VD complex, and 10 g of probiotic microspheres were stirred and mixed for 10 minutes to prepare a composition for alleviating insulin resistance.
[0093] Comparative Example 7
[0094] Compared with Example 3, the difference is that no probiotic microspheres are added in step S6.
[0095] The details are as follows:
[0096] S6. Preparation of a composition for alleviating insulin resistance: 5 g of Panax notoginseng total saponins / ursolic acid complex, 4 g of Panax notoginseng polysaccharide / VD complex, and 1.7 g of berberine / retinol / resveratrol cocrystal were stirred and mixed for 10 minutes to prepare a composition for alleviating insulin resistance.
[0097] Test Example 1
[0098] Male SD rats were selected and fed adaptively for 1 week, and the rats were randomly divided into a blank group (10 rats) and a modeling group. The blank group was given ordinary feed, and the modeling group was fed with a high-fat feed for 8 weeks. In the 9th week, the modeling group was injected with a 2% streptozotocin solution at a dose of 30 mg / kg, and fasted for 8 hours after 72 hours, but not water, and blood was taken from the tail tip vein to measure fasting blood sugar. The modeling rats with fasting blood glucose (FBG)>11.1mmol / L were selected. During the modeling period, 7 modeling rats died, and the modeling rats with fasting blood glucose>30mmol / L were eliminated. The remaining 120 modeling rats were included in the experiment and divided into a model group, a metformin group, an embodiment 1-3 group, and a comparative example 1-7 group, with 10 rats in each group. According to the calculation of 1mL / 100g dosing volume, the blank group and the model group were gavaged with sterile water, the metformin group was gavaged with a dose of 0.3g / kg, and the Example 1-3 group and the Comparative Example 1-7 group were gavaged with a dose of 0.5g / kg for 4 consecutive weeks. During the dosing period, all rats in the group were fed with ordinary feed and had free access to food and water.
[0099] Fasting blood glucose and serum lipid test: After 4 weeks of administration, fasting but not water restriction for 8 hours, blood was collected from the tail vein to measure fasting blood glucose, and then 10% chloral hydrate was used to anesthetize the rats, whole blood was collected through the abdominal aorta, and the whole liver was removed. Liver tissue was taken from the liver lobe, quickly frozen in liquid nitrogen in a cryotube, and stored in a -80°C refrigerator for later use. The blood was centrifuged to obtain the supernatant, and the FINS content was measured by enzyme immunoassay, and the insulin resistance index (HOMA-IR) was calculated. HOMA-IR = (FBG × FINS) / 22. The results are shown in Table 1.
[0100] Table 1
[0101] Group FBG (mmol / L) FINS(IU / mL) HOMA-IR Blank Group 4.59±0.51 12.56±0.92 2.620 Model Group 29.88±3.42* 27.52±4.33* 37.377 Metformin group 23.18±1.28# 22.31±3.25# 23.507 Example 1 12.15±1.56# 17.89±2.14# 9.880 Example 2 11.89±1.24# 17.11±1.95# 9.247 Example 3 11.76±1.09# 17.05±1.78# 9.114 Comparative Example 1 16.87±1.67 21.48±2.45 16.471 Comparative Example 2 17.49±2.21 23.35±2.68 18.563 Comparative Example 3 17.11±1.84 22.87±2.31 17.787 Comparative Example 4 18.52±2.11 24.13±2.19 20.313 Comparative Example 5 18.94±2.23 24.88±2.33 21.419 Comparative Example 6 20.15±2.10 24.66±2.48 22.586 Comparative Example 7 16.78±2.09 22.18±2.18 16.917
[0102] Note: * compared with the blank group, P < 0.05; # compared with the model group, P < 0.05.
[0103] It can be seen from the above table that the compositions for alleviating insulin resistance prepared in Examples 1-3 of the present invention can significantly reduce the blood glucose level of rats, and significantly reduce serum FINS and HOMA-IR.
[0104] Liver tissue homogenate detection: According to the kit operation steps, the liver tissue was homogenized and the SOD and MDA contents were detected by colorimetry; the TNF-α and IL-6 contents were detected by radioimmunoassay. The results are shown in Table 2.
[0105] Table 2
[0106] Group SOD content (U / mg) MDA content (nmol / mg) TNF-α content (pg / mg) IL-6 content (pg / mg) Blank Group 17.29±2.19 1.15±0.12 6.51±1.12 16.67±2.19 Model Group 7.01±1.01* 2.77±0.43* 11.39±2.89* 31.25±3.29* Metformin group 8.34±0.88# 2.29±0.21# 9.77±1.54# 26.59±2.61# Example 1 14.55±1.04# 1.89±0.22# 8.89±1.24# 21.15±2.14# Example 2 14.89±0.97# 1.81±0.18# 8.67±1.09# 20.89±1.88# Example 3 14.94±0.85# 1.79±0.20# 8.59±1.12# 20.75±1.79# Comparative Example 1 11.08±1.24 2.15±0.33 9.41±1.15 23.29±1.95 Comparative Example 2 9.97±1.55 2.09±0.39 9.30±1.32 25.33±2.04 Comparative Example 3 10.25±1.49 2.21±0.28 9.57±1.43 24.18±1.85 Comparative Example 4 10.82±1.72 1.98±0.37 10.49±1.67 25.82±1.99 Comparative Example 5 10.13±1.69 2.09±0.41 10.24±1.82 26.04±2.03 Comparative Example 6 9.02±1.59 2.35±0.33 10.18±1.65 27.66±2.14 Comparative Example 7 11.35±1.92 2.25±0.47 11.44±1.28 26.87±2.27
[0107] Note: * compared with the blank group, P < 0.05; # compared with the model group, P < 0.05.
[0108] As can be seen from the above table, the samples prepared in Examples 1-3 of the present invention can significantly increase the SOD content and reduce the MDA, TNF-α and IL-6 contents.
[0109] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing a composition for alleviating insulin resistance, characterized in that: Panax notoginseng is extracted to obtain Panax notoginseng polysaccharide and Panax notoginseng total saponin, Panax notoginseng polysaccharide is reacted with vitamin D to obtain Panax notoginseng polysaccharide / VD complex, Panax notoginseng total saponin is reacted with ursolic acid to obtain Panax notoginseng total saponin / ursolic acid complex, and the complex is evenly mixed with berberine / retinol / resveratrol cocrystal and probiotic microspheres to obtain a composition for alleviating insulin resistance.
2. The preparation method according to claim 1, characterized in that: The following steps are involved: S1. Extraction of notoginseng polysaccharide and total saponin: adding notoginseng powder to water, heating to boiling for extraction, filtering, retaining the solid residue, adding ethanol to the filtrate for precipitation, filtering, washing, and drying to obtain notoginseng polysaccharide; mixing the filtrate with the solid residue, heating for extraction, filtering, decompressing the filtrate to recover ethanol, adding acetone to the liquid for precipitation, filtering, washing, and drying to obtain notoginseng total saponin; S2. Preparation of Panax notoginseng total saponins / ursolic acid complex: adding Panax notoginseng total saponins to ethanol aqueous solution, adding catalyst and ursolic acid, heating to boiling for reaction, separating the catalyst, adding ether for precipitation, filtering, washing, and drying to obtain Panax notoginseng total saponins / ursolic acid complex; S3. Preparation of Panax notoginseng polysaccharide / VD complex: adding Panax notoginseng polysaccharide to ethanol aqueous solution, adding catalyst and vitamin D, heating to boiling reaction, separating the catalyst, adding acetone for precipitation, filtering, washing, and drying to obtain Panax notoginseng polysaccharide / VD complex; S4. Preparation of cocrystals: dissolving berberine in water to obtain solution A; dissolving retinol in ethanol to obtain solution B; dissolving resveratrol in acetone to obtain solution C; mixing solution A, solution B, and solution C evenly, evaporating them in an open air to form crystals, filtering, washing, and drying to obtain berberine / retinol / resveratrol cocrystals; S5. Preparation of probiotic microspheres: Lactobacillus plantarum, Bifidobacterium lactis, and Bifidobacterium animalis were added to water, sodium alginate, lecithin, and arabinose were added, stirred and mixed, and then added dropwise to fish oil, emulsified, and calcium chloride solution was added dropwise, solidified at room temperature, filtered, washed, and freeze-dried to obtain probiotic microspheres; S6. Preparation of a composition for alleviating insulin resistance: evenly mix notoginseng total saponin / ursolic acid complex, notoginseng polysaccharide / VD complex, berberine / retinol / resveratrol cocrystal, and probiotic microspheres to prepare a composition for alleviating insulin resistance.
3. The preparation method according to claim 2, characterized in that: The solid-to-liquid ratio of Panax notoginseng powder and water in step S1 is 1:5-7g / mL, the time for heating to boiling extraction is 2-4h, ethanol is added until the ethanol content of the system is 75-85wt%, the time for heating extraction is 1-2h, and acetone is added until the acetone content of the system is 70-80wt%.
4. The preparation method according to claim 2, characterized in that: The ethanol content in the ethanol aqueous solution in step S2 is 40-60wt%, the mass ratio of the Panax notoginseng total saponins, the catalyst and ursolic acid is 10:0.1-0.2:4-5, and the time for heating to boiling reaction is 4-6h.
5. The preparation method according to claim 2, characterized in that: The mass ratio of Panax notoginseng polysaccharide, catalyst and vitamin D in step S3 is 12-15:0.1-0.2:3-5, and the time for heating to boiling reaction is 3-5h.
6. The preparation method according to claim 2, characterized in that: In step S4, the mass ratio of berberine, retinol and resveratrol is 1-2:0.5-1:1.2-1.5, and the open volatilization time is 3-5 days.
7. The preparation method according to claim 2, characterized in that: The mass ratio of Lactobacillus plantarum, Bifidobacterium lactis, Bifidobacterium animalis, sodium alginate, lecithin and arabinose in step S5 is 3-5:1-2:2-3:4-6:0.2-0.4:1-2.
8. The preparation method according to claim 2, characterized in that: The mass ratio of the notoginseng total saponins / ursolic acid complex, the notoginseng polysaccharide / VD complex, the berberine / retinol / resveratrol cocrystal, and the probiotic microspheres in step S6 is 4-6:3-5:1-2:
10.
9. The preparation method according to claim 2, characterized in that: The specific steps include: S1. Extraction of notoginseng polysaccharide and total saponin: adding notoginseng powder to water, wherein the solid-liquid ratio of notoginseng powder to water is 1:5-7g / mL, heating to boiling and extracting for 2-4h, filtering, retaining the solid residue, adding ethanol to the filtrate until the ethanol content of the system is 75-85wt%, precipitating, filtering, washing, and drying to obtain notoginseng polysaccharide; mixing the filtrate with the solid residue, heating and extracting for 1-2h, filtering, decompressing the filtrate to recover ethanol, adding acetone to the liquid until the acetone content of the system is 70-80wt%, precipitating, filtering, washing, and drying to obtain notoginseng total saponin; S2. Preparation of Panax notoginseng total saponins / ursolic acid complex: add 10 parts by weight of Panax notoginseng total saponins to an ethanol aqueous solution, add 0.1-0.2 parts by weight of a catalyst and 4-5 parts by weight of ursolic acid, heat to boiling and react for 4-6 hours, separate the catalyst, add ether to precipitate, filter, wash, and dry to obtain a Panax notoginseng total saponins / ursolic acid complex; The ethanol content in the ethanol aqueous solution is 40-60wt%; S3. Preparation of Panax notoginseng polysaccharide / VD complex: adding 12-15 parts by weight of Panax notoginseng polysaccharide to an ethanol aqueous solution, adding 0.1-0.2 parts by weight of a catalyst and 3-5 parts by weight of vitamin D, heating to boiling for 3-5 hours, separating the catalyst, adding acetone for precipitation, filtering, washing, and drying to obtain a Panax notoginseng polysaccharide / VD complex; The ethanol content in the ethanol aqueous solution is 40-60wt%; S4. Preparation of cocrystals: 1-2 parts by weight of berberine was dissolved in water to obtain solution A; 0.5-1 parts by weight of retinol was dissolved in ethanol to obtain solution B; 1.2-1.5 parts by weight of resveratrol was dissolved in acetone to obtain solution C; solution A, solution B, and solution C were mixed uniformly, and evaporated open for 3-5 days to form crystals, which were filtered, washed, and dried to obtain berberine / retinol / resveratrol cocrystals; S5. Preparation of probiotic microspheres: 3-5 parts by weight of Lactobacillus plantarum, 1-2 parts by weight of Bifidobacterium lactis, 2-3 parts by weight of Bifidobacterium animalis were added to water, 4-6 parts by weight of sodium alginate, 0.2-0.4 parts by weight of lecithin and 1-2 parts by weight of arabinose were added, stirred and mixed, and then added dropwise to fish oil, emulsified, and calcium chloride solution was added dropwise, solidified at room temperature, filtered, washed, and freeze-dried to obtain probiotic microspheres; S6. Preparation of a composition for alleviating insulin resistance: mix 4-6 parts by weight of Panax notoginseng total saponins / ursolic acid complex, 3-5 parts by weight of Panax notoginseng polysaccharide / VD complex, 1-2 parts by weight of berberine / retinol / resveratrol cocrystal, and 10 parts by weight of probiotic microspheres to obtain a composition for alleviating insulin resistance.
10. A composition for alleviating insulin resistance obtained according to the preparation method according to any one of claims 1 to 9.
